Intramuscular Injection Guideline Revisions are Needed Based on Body Mass Index, Needle Length, Sex, and Skin to Muscle Depth
Main Article Content
Abstract
Background: Medications and vaccines are delivered via intramuscular injection throughout the world to improve health and to prevent or treat illness. Intramuscular injections are an essential nursing and pharmacist skill which includes choosing an appropriate injection site and selecting needle lengths and gages based on weight and muscle mass. Scientific evidence suggests changes in current practice and national guidelines to fully reach medication and vaccine efficacy.
Results: There is a direct relationship between medication/vaccine efficacy and health outcomes. The variance in weight provides vital information on the needle length and site of injection. Body mass index, age, sex, and skin to muscle depth are important measures when choosing the right needle length and site for an intramuscular injection.
The literature draws attention to deltoid injection concerns. The standard 25 mm needles may not be appropriate for small or large and obese populations as there can be reduced efficacy if the medication or vaccine is not deposited into the muscle. Other concerns include medications and vaccines deposited in the shoulder bursa in some patients instead of the deltoid pad causing pain, limited range of motion, and long-lasting disabilities.
Dorsogluteal and ventrogluteal sites are used for deep gluteal muscle injections. The ventrogluteal is the most appropriate site for deep muscle injections yet many nurses prefer the dorsogluteal site because of preference/comfort with the procedure. Deep gluteal injections often require longer needles to reach the muscle mass in large or obese patients, especially women.
Intramuscular injection guidelines are followed by clinicians worldwide. Agencies/centers such as the Centers for Disease Control and Prevention update these guidelines as needed but most national guidelines lack specific intramuscular injection instructions. Clinicians usually perform clinical procedures taught in basic training and follow national guidelines rather than performing individual clinical assessments.
Conclusion: Improving public health is vital, especially in various weighted populations that may not be receiving optimal efficacy of medications and vaccines. Updates to guidelines and continuous education and training in injection techniques should be a priority in all health agencies worldwide.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Chhabria S, Fatima CS. A long shot: The importance of needle length in vaccinating patients with obesity against COVID-19. Vaccine. 2022;40(1):9-10. doi.org/10.1016/j.vaccine.2021.11.008
3. De Sanctis JB, Balda Noria G, García AH. Exploring How Adipose Tissue, Obesity, and Gender Influence the Immune Response to Vaccines: A Comprehensive Narrative Review. International Journal of Molecular Sciences. 2025; 26(2):862. https://doi.org/10.3390/ijms26020862
4. Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook 2023. Accessed March 10, 2025. https://immunisationhandbook.health.gov.au/resources/tables/table-recommended-needle-size-length-and-angle-for-administering-vaccines
5. Centers for Disease Control and Prevention (CDC). (2024). Vaccine recommendations and guidelines of the ACIP: Vaccine administration. Accessed March 10, 2025, from https://www.cdc.gov/vaccines/hcp/imz-best-practices/vaccine-administration.html?
6. Green-Book-Chapter-4.pdf. Accessed March 10, 2025 https://assets.publishing.service.gov.uk/media/5a7afc62e5274a34770e88e5/Green-Book-Chapter-4.pdf
7. Ministry of Health. Processes for safe immunisation. Immunisation Handbook 2024. Accessed March 10, 2025, from https://www.tewhatuora.govt.nz/for-health-professionals/clinical-guidance/immunisation-handbook
8. Nasr MC, Geerling E, Pinto AK. Impact of Obesity on Vaccination to SARS-CoV-2. Front Endocrinol (Lausanne). 2022;13:898810. doi:10.3389/fendo.2022.898810
9. Tuthill D, McFarlane A. Preventing food allergy fatalities: epinephrine auto-injector doses in the BNFC. Arch Dis Child. 2024;109(3):260. doi: https://doi.org/10.1136/archdischild-2023-326632
10. Holliday RM, Gupta V, Vibhute PG. Body mass index: A reliable predictor of subcutaneous fat thickness and needle length for ventral gluteal intramuscular injections. Am J Ther. 2019 Jan/Feb;26(1):e72-e78. doi: 10.1097/MJT.0000000000000474
11. World Obesity 2025. Accessed April 6, 2025, at https://data.worldobesity.org/rankings/
12. Ronnie S. (2022). Statistical estimation of deltoid subcutaneous fat pad thickness: Implications for needle length for vaccination. Scientific Reports (Nature Publisher Group). 2022;12(1). doi: https://doi.org/10.1038/s41598-022-05020-5
13. Mardourian M, Hao KA, Wiggins W, et al. (2023). Optimizing needle length and site choice for adult immunization. Vaccine. 2023;41(33) 4836-4843. https://doi.org/10.1016/j.vaccine.2023.06.031
14. Doppen M, Black M, Braithwaite I, et al. Skin-to-deltoid-muscle distance at three recommended sites for intramuscular vaccination in a population with obesity: An observational study. The New Zealand Medical Journal (Online). 2023;136(1573):67-76. doi: 10.26635/6965.5915
15. Doppen M, Kearns C, Weatherall M, et al. When should a longer needle be used for intramuscular injection in obese patients? A combined analysis of New Zealand data. Vaccine. 2023;Apr 17;41(16):2690-2695. doi:10.1016/j.vaccine.2023.03.018
16. Rahamimov N, Baturov V, Shani A, Ilai BZ, Fischer D, Chernihovsky A. Inadequate deltoid muscle penetration and concerns of improper COVID mRNA vaccine administration can be avoided by injection technique modification. Vaccine. 2021;39(37):5326-5330. https://doi.org/10.1016/j.vaccine.2021.06.081
17. Lau, R. (2024). Choosing wisely: Needle length and gauge considerations for intramuscular and subcutaneous injections. Australian Journal of Advanced Nursing (Online). 2024;41(3): 40-49. Retrieved from https://www.ajan.com.au/~ajancoma/index.php/AJAN/article/view/1235
18. Alzahrani WM. (2023). Do COVID-19 vaccines cause shoulder injuries: A survey among health care providers at Najran University Hospital. Cardiometry. 2023;26:168-176. doi:10.18137/cardiometry.2023.26.168176
19. Bass JR, Poland GA. Shoulder injury related to vaccine administration (SIRVA) after COVID-19 vaccination. Vaccine. 2022;Aug12;40(34):4964-4971. doi:10.1016/j.vaccine.2022.06.002.
20. Mackenzie LJ, Bushell MA, Newman P, Bousie JA. Shoulder injury related to vaccine administration (SIRVA): What do we know about its incidence and impact? Explor Res Clin Soc Pharm. 2022 Sep 26;8:100183. doi: 10.1016/j.rcsop.2022.100183
21. World Health Association (2016). WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal, and subcutaneous injections in health care settings. ISBN: 978 92 4 154982 0. Accessed March 23, 2025, https://www.who.int/activities/preparing-and-preventing-epidemics-and-pandemics
22. Worm M, Fox AT, Wickman M, et al. Adrenaline auto injectors pharmacokinetic/pharmacodynamic studies and potential consequences for clinical practice. Clinical and Translational Allergy. 2023;13(12). doi: 10.1002/clt2.12323.
23. Kaya N, Turan N, Salmaslioğlu A, Akçakaya AA. Needle penetration depth according to gender and body mass index in ventrogluteal intramuscular injections in adults. Journal of Istanbul Faculty of Medicine/İstanbul Tıp Fakültesi Dergisi. 2023;86(4): 384-392. doi:10.26650/IUITFD.1266488
24. Fekonja U, Fekonja, Zvonka M, Vrbnjak D. (2021). The assessment of knowledge and practical skills of intramuscular injection administration among nursing staff: A cross sectional study. Australian Journal of Advanced Nursing (Online). 2021;38(3): 33-42. doi.org/10.37464/2020.383.234
25. Kaynar Şimşek A, Okuroğlu G, Çaylı N, Alpar Ecevit Ş. The effect of structured education on nurses’ ventrogluteal injection knowledge and skills. Clinical and Experimental Health Sciences. March 2024;14(1):107-113. doi:10.33808/clinexphealthsci.1215219
26. Yalcin AN, Altan MD, Kaymaz E. Examining the safety of dorsogluteal and ventrogluteal sites for intramuscular injection in older adults. International Journal of Older People Nursing. 2024;19(6):1-8. doi:10.1111/opn.12655
27. Kilroy G, Lorbiecki M, Ndakuya-Fitzgerald F, Hagle M. Supporting the Safe Use of the Dorsogluteal Intramuscular Injection Site: An Evidence-Based Quality Improvement Project. Journal of the American Psychiatric Nurses Association. 2024;30(4):819-827. doi:10.1177/10783903231178556
28. Weber, Heidi, M.N., R.N. Deciding on a safe site for intramuscular injections in an acute mental health setting. Kaitiaki Nursing Research. 2023;14(1):58-61. Accessed from https://search.informit.org/doi/10.3316/informit.T2024030400001690574725172.
29. Erstad BL, Barletta JF. Implications of obesity for drug administration and absorption from subcutaneous and intramuscular injections: A primer. American Journal of Health-System Pharmacy. 2022;79(15):1236-1244. doi:10.1093/ajhp/zxac058
30. Roldán-Chicano MT, Rodríguez-Tello J, Cebrián-López R, Moore JR, García-López M. Adverse effects of dorsogluteal intramuscular injection versus ventrogluteal intramuscular injection: A systematic review and meta-analysis. Nursing Open. 2023;10(9):5975-5988. doi:https://doi.org/10.1002/nop2.1902
31. Strohfus P, Palma S, Wallace CT. Dorsogluteal intramuscular injection depth needed to reach muscle tissue according to body mass index and gender: A systematic review. Journal of Clinical Nursing. 2022;31(19/20):2943-2958. doi:10.1111/jocn.16126
32. Wodi, A.P., Shimabukuro, T. (2021). Chapter 4: Vaccine safety. In E. Hall and others (Eds.), Epidemiology and prevention of vaccine-preventable diseases (14th ed., pp. 43-52). Centers for Disease Control and Prevention (CDC). Washington, DC: Public Health Foundation. Centers for Disease Control and Prevention (CDC). (2023). Pink Book. Accessed March 10, 2025 from https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-4-vaccine-safety.html?
33. Centers for Disease Control and Prevention (CDC). (2023). Accessed March 10 2025 at https://www.cdc.gov/vaccines/hcp/admin/downloads/vaccine-administration-needle-length.pdf
34. Centers for Disease Control and Prevention (CDC). Accessed March 21, 2025. https://www.cdc.gov/bmi/about/index.html
35. Poland GA, Borrud A, Jacobson RM, et al. Determination of deltoid fat pad thickness: implications for needle length in adult immunization. JAMA. 1997;277:1709-11.
36. Zuckerman JN. The importance of injecting vaccines into muscle. Different patients need different needle sizes. BMJ. 2000 Nov 18;321(7271):1237-8. doi: 10.1136/bmj.321.7271.1237.
37. Hemingway S, Steve Lui, White J. Considering skin-to-muscle depth for successful intramuscular injections in an increasingly obese population. British Journal of Nursing. 2023;32(13):628-635. doi:10.12968/bjon.2023.32.13.628